NO20004953D0 - Triazolpurinderivater, farmasøytisk sammensetning inneholdende derivatene, adenosin-A 3-reseptor ligand og astmamiddel - Google Patents

Triazolpurinderivater, farmasøytisk sammensetning inneholdende derivatene, adenosin-A 3-reseptor ligand og astmamiddel

Info

Publication number
NO20004953D0
NO20004953D0 NO20004953A NO20004953A NO20004953D0 NO 20004953 D0 NO20004953 D0 NO 20004953D0 NO 20004953 A NO20004953 A NO 20004953A NO 20004953 A NO20004953 A NO 20004953A NO 20004953 D0 NO20004953 D0 NO 20004953D0
Authority
NO
Norway
Prior art keywords
derivatives
adenosine
composition containing
triazole
pharmaceutical composition
Prior art date
Application number
NO20004953A
Other languages
English (en)
Other versions
NO20004953L (no
NO317709B1 (no
Inventor
Takashi Okamura
Yasuhisa Kurogi
Hiroshi Nishikawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO20004953D0 publication Critical patent/NO20004953D0/no
Publication of NO20004953L publication Critical patent/NO20004953L/no
Publication of NO317709B1 publication Critical patent/NO317709B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20004953A 1998-04-03 2000-10-02 Triazolpurinderivater, farmasoytisk sammensetning inneholdende derivatene, adenosin-A3-reseptor ligand og astmamiddel NO317709B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9136798 1998-04-03
JP28919498 1998-10-12
PCT/JP1999/001592 WO1999051606A1 (en) 1998-04-03 1999-03-26 Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine a3 receptor compatibilizing agent, and asthmatic remedy

Publications (3)

Publication Number Publication Date
NO20004953D0 true NO20004953D0 (no) 2000-10-02
NO20004953L NO20004953L (no) 2000-11-28
NO317709B1 NO317709B1 (no) 2004-12-06

Family

ID=26432810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004953A NO317709B1 (no) 1998-04-03 2000-10-02 Triazolpurinderivater, farmasoytisk sammensetning inneholdende derivatene, adenosin-A3-reseptor ligand og astmamiddel

Country Status (13)

Country Link
US (1) US6288070B1 (no)
EP (1) EP1069126B1 (no)
JP (1) JP4077155B2 (no)
KR (1) KR100513062B1 (no)
CN (1) CN1122033C (no)
AT (1) ATE241629T1 (no)
AU (1) AU760399B2 (no)
CA (1) CA2326716C (no)
DE (1) DE69908335T2 (no)
ES (1) ES2195545T3 (no)
NO (1) NO317709B1 (no)
TW (1) TW553945B (no)
WO (1) WO1999051606A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU768520B2 (en) 1999-09-28 2003-12-18 Otsuka Pharmaceutical Factory, Inc. Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
KR20030076633A (ko) * 2001-02-05 2003-09-26 가부시키 가이샤 오오쯔카 세이야쿠 고우죠우 트리아조로퀴나졸린 및 피라졸로 트리아조로피리미딘유도체, 의약조성물,아데노신 에이3 수용체 친화제,안압저하제, 녹내장의 예방 및 치료를 위한 제제 및안압저하 방법
KR100687954B1 (ko) 2001-10-15 2007-02-27 쉐링 코포레이션 아데노신 Ａ2ａ 수용체 길항제로서의이미다조（4,3-ｅ）-1,2,4-트리아졸로（1,5-ｃ） 피리미딘
WO2011010306A1 (en) 2009-07-21 2011-01-27 Ramot At Tel-Aviv University Ltd. A3 adenosine receptor ligands for modulation of pigmentation
IL275817B2 (en) * 2018-01-04 2024-04-01 Impetis Biosciences Ltd Tricyclic compounds, compositions and medicinal applications thereof
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677445D1 (de) * 1985-09-30 1991-03-14 Ciba Geigy Ag 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
ES2051772T3 (es) * 1986-09-30 1994-07-01 Ciba Geigy Ag 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
IT1277392B1 (it) * 1995-07-28 1997-11-10 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
CA2239881A1 (en) * 1996-10-07 1998-04-16 Nobuo Kosaka Condensed purine derivatives

Also Published As

Publication number Publication date
DE69908335D1 (de) 2003-07-03
NO20004953L (no) 2000-11-28
ES2195545T3 (es) 2003-12-01
EP1069126A1 (en) 2001-01-17
KR20010042240A (ko) 2001-05-25
CN1301266A (zh) 2001-06-27
CA2326716C (en) 2006-12-12
WO1999051606A1 (en) 1999-10-14
TW553945B (en) 2003-09-21
CN1122033C (zh) 2003-09-24
CA2326716A1 (en) 1999-10-14
AU760399B2 (en) 2003-05-15
JP4077155B2 (ja) 2008-04-16
KR100513062B1 (ko) 2005-09-05
NO317709B1 (no) 2004-12-06
DE69908335T2 (de) 2004-04-29
US6288070B1 (en) 2001-09-11
EP1069126B1 (en) 2003-05-28
ATE241629T1 (de) 2003-06-15
AU2856899A (en) 1999-10-25
EP1069126A4 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
BR0007500A (pt) Composto triazol, fármaco, e, uso do composto
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
PL300063A1 (en) 7-(substituted)-9-[(substituted glycil) amido]-6-demethyl-6-deoxy-tetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts and metal complex, pharmaceutical agent and veterinary agent
FI942075A0 (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
WO1999064409A3 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
FI93831B (fi) Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita
PL300062A1 (en) Novel 7-(substituted)-8-(substituted)-9-[(substituted glycil) amido]-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts and metal complex, pharmaceutical agent and veterinary agent
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
ATE178332T1 (de) Benzothiadiazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zuzammensetzungen
NO20004953D0 (no) Triazolpurinderivater, farmasøytisk sammensetning inneholdende derivatene, adenosin-A 3-reseptor ligand og astmamiddel
CA2143252A1 (fr) Derives de benzodioxane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK1086071T3 (da) Hyperforinforbindelser, anvendelse heraf og formuleringer indeholdende disse
DE69600272D1 (de) Chinolin-4-carbonylguanidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK283984A (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
ATE123497T1 (de) Substituierte pyridin-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE59004292D1 (de) Renin-hemmende Aminooligohydroxy-Derivate.
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
SE9803280D0 (sv) Novel compounds
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
ATE265459T1 (de) Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
DE69400283D1 (de) (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees